M3-selective positive allosteric modulator

oral bioavailability in rodent

from HTS and optimization

Bioorg. Med. Chem. Apr. 23, 2020

Astellas Pharma, Tsukuba, JP

Compound 9

“Compound 9” is the first potent M3-selective positive allosteric modulator, with potential utility as a biological tool compound. It does have secondary activity against M5 at high doses though. It’s…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: